Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation
NCT01530581 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 230
Last updated 2018-08-10
Summary
This is a Randomized Multicentre study Comparing GCSF Mobilized Peripheral Blood and GCSF stimulated Bone Marrow in Patients undergoing matched sibling Transplantation for Haematologic Malignancies.
Conditions
- Transplantation for Hematologic Malignancies
Interventions
- PROCEDURE
-
G-PB Transplant
G-PB Transplant
- PROCEDURE
-
G-BM Transplant
G-BM Transplant
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Mahmoud Al Jurf, MD · King Faisal Specialist Hospital & Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2012-06-30
- Completion
- 2014-06-30
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies
NCT02386332 ·Status: UNKNOWN
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
NCT05290545 ·Status: COMPLETED ·Phase: PHASE3
-
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
NCT06208137 ·Status: RECRUITING ·Phase: NA
-
Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
NCT07305090 ·Status: RECRUITING
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
NCT00001748 ·Status: COMPLETED ·Phase: PHASE1
-
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
NCT05629260 ·Status: RECRUITING
-
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
NCT00001872 ·Status: COMPLETED
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.
NCT06837987 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
Musculoskeletal Outcomes After Bone Marrow Transplant
NCT00558948 ·Status: COMPLETED
-
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
NCT05768035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Tissue-resident Immune Cell Subsets in aGVHD
NCT06708507 ·Status: RECRUITING
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
NCT04571203 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors
NCT01751997 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT
NCT04738981 ·Status: COMPLETED ·Phase: PHASE3
-
Functional Assessment of Cancer Therapy - Bone Marrow Transplant
NCT01490957 ·Status: UNKNOWN
-
T-Cell Depletion in Unrelated Donor Marrow Transplantation
NCT00000591 ·Status: COMPLETED ·Phase: PHASE3